No abstract available
MeSH terms
-
Adult
-
Angiogenesis Inhibitors / therapeutic use
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Arthritis / complications*
-
Arthritis / drug therapy*
-
Bevacizumab
-
Female
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / adverse effects
-
Melanoma / drug therapy*
-
Melanoma / pathology*
-
Neoplasm Invasiveness
-
Neoplasm Staging
-
Patient Care Team
-
Prognosis
-
Risk Factors
-
Sentinel Lymph Node Biopsy
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / pathology*
-
Treatment Outcome
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal, Humanized
-
Immunosuppressive Agents
-
Bevacizumab